Qiao Liao
Research Subjects
Qiao Liao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Yongshui Fu
Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China
7 shared publications Chengyao Li
Affiliation School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China
5 shared publications- Jieting Huang
State Grid Fujian Electric Power Co., Ltd. Electric Power Science Research Institute, Fujian, People's Republic of China
5 shared publications - Ru Xu
Institute of Blood Transfusion Guangzhou Blood Center Guangzhou China
4 shared publications Xia Rong
Institute of Blood Transfusion Guangzhou Blood Center Guangzhou Guangdong China
4 shared publications- Xia Rong
Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, China
4 shared publications
Latest Publications
- Open Access
- 4 February 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (2) , e0009043
Prevalence and evolutionary analyses of human T-cell lymphotropic virus in Guangdong province, China: Transcontinental and Japanese subtype lineages dominate the prevalence
To systematically characterize the prevalence and evolution of human T-cell lymphotropic virus (HTLV) infection among voluntary blood donors (BDs) in Guangdong province, China. A three-year survey for HTLV epidemiology among BDs was performed in Guangdong during 2016–2018. Anti-HTLV-1/2 was screened by ELISA and ECLIA, and subsequently confirmed by western blot (WB) and nucleic acid testing (NAT). The prevalence of HTLV in donors from different cities was calculated. The identified HTLV-positive cases were phylogenetically genotyped and analyzed in a Bayesian phylogenetic framework. Among 3,262,271 BDs, 59 were confirmed positive for HTLV-1 (1.81 per 100,000) and no HTLV-2 infection was found. The prevalence of HTLV-1 varied significantly among 21 cities in Guangdong province, China. The highest prevalence was found in donors from Shanwei (13.94 per 100,000), which is a coastal city in eastern Guangdong. Viral genomic sequences genotyped from 55 HTLV-1 carriers showed that 39 were transcontinental subtype and 16 were Japanese subtype. Specially, 13 out of 39 transcontinental subtype sequences were characterized with L55P mutation and 21 out of 55 sequences were characterized with L19F mutation in viral gp46 protein. The L55P mutation seemed be specific to eastern Asia since it only presented in the sequences from Japan, mainland China, and Taiwan. Phylogenetic analysis of gp46 gene shows that HTLV-1a may have been introduced to Guangdong through four different introduction events and formed major transmission clusters: clades I(13,602 years ago), II(16, 010 years ago), III(15,639 years ago) and IV(16,517 years ago). In general, Guangdong is considered to be a low-prevalence region for HTLV-1 infection, but the prevalence is significantly higher in Shanwei city. Transcontinental and Japanese subtype lineages dominate the prevalence in Guangdong. In terms of blood safety, HTLV antibody screening for first-time blood donors can effectively reduce the risk of HTLV transmission.
- 4 February 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (2) , e0009043
Open AccessPrevalence and evolutionary analyses of human T-cell lymphotropic virus in Guangdong province, China: Transcontinental and Japanese subtype lineages dominate the prevalence
To systematically characterize the prevalence and evolution of human T-cell lymphotropic virus (HTLV) infection among voluntary blood donors (BDs) in Guangdong province, China. A three-year survey for HTLV epidemiology among BDs was performed in Guangdong during 2016–2018. Anti-HTLV-1/2 was screened by ELISA and ECLIA, and subsequently confirmed by western blot (WB) and nucleic acid testing (NAT). The prevalence of HTLV in donors from different cities was calculated. The identified HTLV-positive cases were phylogenetically genotyped and analyzed in a Bayesian phylogenetic framework. Among 3,262,271 BDs, 59 were confirmed positive for HTLV-1 (1.81 per 100,000) and no HTLV-2 infection was found. The prevalence of HTLV-1 varied significantly among 21 cities in Guangdong province, China. The highest prevalence was found in donors from Shanwei (13.94 per 100,000), which is a coastal city in eastern Guangdong. Viral genomic sequences genotyped from 55 HTLV-1 carriers showed that 39 were transcontinental subtype and 16 were Japanese subtype. Specially, 13 out of 39 transcontinental subtype sequences were characterized with L55P mutation and 21 out of 55 sequences were characterized with L19F mutation in viral gp46 protein. The L55P mutation seemed be specific to eastern Asia since it only presented in the sequences from Japan, mainland China, and Taiwan. Phylogenetic analysis of gp46 gene shows that HTLV-1a may have been introduced to Guangdong through four different introduction events and formed major transmission clusters: clades I(13,602 years ago), II(16, 010 years ago), III(15,639 years ago) and IV(16,517 years ago). In general, Guangdong is considered to be a low-prevalence region for HTLV-1 infection, but the prevalence is significantly higher in Shanwei city. Transcontinental and Japanese subtype lineages dominate the prevalence in Guangdong. In terms of blood safety, HTLV antibody screening for first-time blood donors can effectively reduce the risk of HTLV transmission.
- Open Access
- 19 August 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (3) , 1743-1747
Low prevalence of antibodies against SARS‐CoV‐2 among voluntary blood donors in Guangzhou, China
Since the first case of COVID‐19 reported in late December of 2019 in Wuhan, China, the SARS‐CoV‐2 virus has caused approximately 20 million infections and 732 thousand deaths around the world by 11 August 2020. Although the pathogen generally infects the respiratory system, whether it is present in the bloodstream and whether it poses a threat to the blood supply during the period of the outbreak is of serious public concern. In this study, we used enzyme‐linked immunosorbent assay (ELISA) to screen total antibodies against SARS‐CoV‐2 in 2199 blood donors, who had donated blood at the Guangzhou Blood Center during the epidemic. The Ig‐reactive samples were further characterized for IgA, IgG, and IgM subtypes by ELISA and viral nucleic acid by real‐time polymerase chain reaction. Among the 2199 plasma samples, seven were reactive under total antibodies' screening. Further testing revealed that none of them had detectable viral nucleic acid or IgM antibody, but two samples contained IgA and IgG. The IgG antibody titers of both positive samples were 1:16 and 1:4, respectively. Our results indicated a low prevalence of past SARS‐CoV‐2 infection in our blood donors, as none of the tests were positive for viral nucleic acid and only 2 out of 2199 (0.09%) of samples were positive for IgG and IgA. There would be a limited necessity for the implementation of such testing in blood screening in a COVID‐19 low‐risk area.
- 19 August 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (3) , 1743-1747
Open AccessLow prevalence of antibodies against SARS‐CoV‐2 among voluntary blood donors in Guangzhou, China
Since the first case of COVID‐19 reported in late December of 2019 in Wuhan, China, the SARS‐CoV‐2 virus has caused approximately 20 million infections and 732 thousand deaths around the world by 11 August 2020. Although the pathogen generally infects the respiratory system, whether it is present in the bloodstream and whether it poses a threat to the blood supply during the period of the outbreak is of serious public concern. In this study, we used enzyme‐linked immunosorbent assay (ELISA) to screen total antibodies against SARS‐CoV‐2 in 2199 blood donors, who had donated blood at the Guangzhou Blood Center during the epidemic. The Ig‐reactive samples were further characterized for IgA, IgG, and IgM subtypes by ELISA and viral nucleic acid by real‐time polymerase chain reaction. Among the 2199 plasma samples, seven were reactive under total antibodies' screening. Further testing revealed that none of them had detectable viral nucleic acid or IgM antibody, but two samples contained IgA and IgG. The IgG antibody titers of both positive samples were 1:16 and 1:4, respectively. Our results indicated a low prevalence of past SARS‐CoV‐2 infection in our blood donors, as none of the tests were positive for viral nucleic acid and only 2 out of 2199 (0.09%) of samples were positive for IgG and IgA. There would be a limited necessity for the implementation of such testing in blood screening in a COVID‐19 low‐risk area.
- 29 June 2019
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (10) , 1830-1836
Association of HLA‐DQB1*03:01 and DRB1*11:01 with spontaneous clearance of hepatitis C virus in Chinese Li ethnicity, an ethnic group genetically distinct from Chinese Han ethnicity and infected with unique HCV subtype
Specific human leukocyte antigen (HLA) class I and class II alleles have been associated with spontaneous clearance or persistent infection of hepatitis C virus (HCV), which seemed to be restricted by the host's ethnicity and viral genotype. Recently we reported a high prevalence and spontaneous clearance rate of HCV in a cohort of Chinese Li ethnicity who were infected with new variants of HCV genotype 6. In this study, we found that the distribution of HLA class I and class II alleles in HCV infected individuals of Chinese Li ethnicity (n = 143) was distinct from that of Chinese Han ethnicity which was reported in our previous study. HLA‐DRB1*11:01 and DQB1*03:01 were more prevalent in Chinese Li subjects who cleared HCV spontaneously than those who were chronically infected (P = .036 and P = .024, respectively), which were consistent with our previous report regarding the Chinese Han population. Multivariate logistic regression analysis showed that DQB1*03:01 (odds ratio = 3.899, P = .017), but not DRB1*11:01, associated with HCV spontaneous clearance, independent of age, sex, and IFNL3 genotype. Because DQB1*03:01 and DRB1*11:01 were tightly linked because of linkage disequilibrium, our results clearly supported the associations of these two alleles with HCV spontaneous clearance in Chinese Li as well as Han ethnicity.
- 29 June 2019
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (10) , 1830-1836
Association of HLA‐DQB1*03:01 and DRB1*11:01 with spontaneous clearance of hepatitis C virus in Chinese Li ethnicity, an ethnic group genetically distinct from Chinese Han ethnicity and infected with unique HCV subtype
Specific human leukocyte antigen (HLA) class I and class II alleles have been associated with spontaneous clearance or persistent infection of hepatitis C virus (HCV), which seemed to be restricted by the host's ethnicity and viral genotype. Recently we reported a high prevalence and spontaneous clearance rate of HCV in a cohort of Chinese Li ethnicity who were infected with new variants of HCV genotype 6. In this study, we found that the distribution of HLA class I and class II alleles in HCV infected individuals of Chinese Li ethnicity (n = 143) was distinct from that of Chinese Han ethnicity which was reported in our previous study. HLA‐DRB1*11:01 and DQB1*03:01 were more prevalent in Chinese Li subjects who cleared HCV spontaneously than those who were chronically infected (P = .036 and P = .024, respectively), which were consistent with our previous report regarding the Chinese Han population. Multivariate logistic regression analysis showed that DQB1*03:01 (odds ratio = 3.899, P = .017), but not DRB1*11:01, associated with HCV spontaneous clearance, independent of age, sex, and IFNL3 genotype. Because DQB1*03:01 and DRB1*11:01 were tightly linked because of linkage disequilibrium, our results clearly supported the associations of these two alleles with HCV spontaneous clearance in Chinese Li as well as Han ethnicity.
- 31 October 2018
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (2) , 330-335
Characterization of monocytic and granulocytic subsets of myeloid‐derived suppressor cells in blood donors with occult hepatitis B virus infection
Myeloid‐derived suppressor cells (MDSCs) accumulate from many diseases. MDSCs are rarely explored in occult hepatitis B virus infection (OBI). The frequency of monocytic MDSCs (M‐MDSCs) and granulocytic MDSCs (G‐MDSCs) in OBI carriers was analyzed for correlation with clinical parameters, which was no different between OBI and healthy individuals, whereas the frequency of M‐MDSCs but G‐MDSCs in OBI was significantly lower than that observed in chronic hepatitis B carriers (0.4% vs 0.7%, P = 0.0004). The frequency of MDSCs was not correlated with clinical parameters and viral load of OBI, suggesting that the absence of HBsAg in OBI carriers might not induce the accumulation of MDSCs.
- 31 October 2018
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (2) , 330-335
Characterization of monocytic and granulocytic subsets of myeloid‐derived suppressor cells in blood donors with occult hepatitis B virus infection
Myeloid‐derived suppressor cells (MDSCs) accumulate from many diseases. MDSCs are rarely explored in occult hepatitis B virus infection (OBI). The frequency of monocytic MDSCs (M‐MDSCs) and granulocytic MDSCs (G‐MDSCs) in OBI carriers was analyzed for correlation with clinical parameters, which was no different between OBI and healthy individuals, whereas the frequency of M‐MDSCs but G‐MDSCs in OBI was significantly lower than that observed in chronic hepatitis B carriers (0.4% vs 0.7%, P = 0.0004). The frequency of MDSCs was not correlated with clinical parameters and viral load of OBI, suggesting that the absence of HBsAg in OBI carriers might not induce the accumulation of MDSCs.
- 1 September 2018
- Published by AME Publishing Company in Annals of Blood
- Vol. 3, 40
Low prevalence of human T lymphocyte virus in blood donors in Guangdong, China
Background: To investigate the prevalence of human T lymphocyte virus (HTLV) in blood donors in Guangdong province, China. Methods: The enzyme-linked immunosorbent assay (ELISA) was applied for primary screening of anti-HTLV-I/II antibodies in blood donors. Reactive samples were subjected to secondary detection using the electrochemiluminescence immunoassay (ECLIA). Samples reactive for both ELISA and ECLIA were further identified by nucleic acid testing (NAT) and Western-blot (WB). Results: A total of 2,058,790 samples collected from 20 blood stations across the whole province of Guangdong were screened through March 2016 to February 2018. Among them, 758 samples were reactive with ELISA, and 182 were reactive with followed ECLIA detection. Of ECLIA reactive samples, 43 were identified positive by NAT and WB, accounting for an overall positive rate of 0.002% (43/2,058,790). Forty-three positive samples were classified as HTLV-I, and no HTLV-II was identified. Conclusions: The prevalence of HTLV-I was approximately 1:50,000, that was low in blood donor population in Guangdong province. In term of blood safety, a leukocyte filtration for blood components might reduce the risk of HTLV-1 transmission in transfusion, which could be also considered as an alternative of high cost blood screening by the immunoassays and NAT for the viruses in blood donation.
- 1 September 2018
- Published by AME Publishing Company in Annals of Blood
- Vol. 3, 40
Low prevalence of human T lymphocyte virus in blood donors in Guangdong, China
Background: To investigate the prevalence of human T lymphocyte virus (HTLV) in blood donors in Guangdong province, China. Methods: The enzyme-linked immunosorbent assay (ELISA) was applied for primary screening of anti-HTLV-I/II antibodies in blood donors. Reactive samples were subjected to secondary detection using the electrochemiluminescence immunoassay (ECLIA). Samples reactive for both ELISA and ECLIA were further identified by nucleic acid testing (NAT) and Western-blot (WB). Results: A total of 2,058,790 samples collected from 20 blood stations across the whole province of Guangdong were screened through March 2016 to February 2018. Among them, 758 samples were reactive with ELISA, and 182 were reactive with followed ECLIA detection. Of ECLIA reactive samples, 43 were identified positive by NAT and WB, accounting for an overall positive rate of 0.002% (43/2,058,790). Forty-three positive samples were classified as HTLV-I, and no HTLV-II was identified. Conclusions: The prevalence of HTLV-I was approximately 1:50,000, that was low in blood donor population in Guangdong province. In term of blood safety, a leukocyte filtration for blood components might reduce the risk of HTLV-1 transmission in transfusion, which could be also considered as an alternative of high cost blood screening by the immunoassays and NAT for the viruses in blood donation.
- 3 August 2018
- Published by Wiley in Transfusion Medicine
- Vol. 28 (6) , 468-469
Sero‐prevalence and viremia status of dengue virus among asymptomatic blood donors post epidemic outbreak in Chinese Guangzhou in 2015
- 3 August 2018
- Published by Wiley in Transfusion Medicine
- Vol. 28 (6) , 468-469
Sero‐prevalence and viremia status of dengue virus among asymptomatic blood donors post epidemic outbreak in Chinese Guangzhou in 2015
- 15 February 2018
- Published by Wiley in Transfusion
- Vol. 58 (4) , 1028-1035
Association of killer cell immunoglobulin‐like receptors with spontaneous clearance of hepatitis C virus in the Chinese population
BACKGROUND: Natural killer (NK) cells are critical components in innate immune response to viral infection. Killer cell immunoglobulin‐like receptors (KIRs) are involved in regulating the balance of activation or inhibitory function of NK cells. However, the association of KIRs with the spontaneous clearance of hepatitis C virus (HCV) remains unclear in the Chinese population.STUDY DESIGN AND METHODS: A total of 407 HCV‐seropositive voluntary blood donors were recruited, including 203 with spontaneous viral clearance and 204 with chronic infection. The presence of KIR genes was detected individually by polymerase chain reaction with sequence‐specific primers. Data of HLA and interleukin‐28B (IL28B) genotypes were extracted from our previous study.RESULTS: Our results showed that KIR2DL2, 2DS2, 2DL2/2DL3, and 2DL5A–/2DL5B+ were more frequent in subjects with HCV clearance than those with chronic infection (odds ratio [OR], 1.640, p = 0.034; OR, 1.664, p = 0.032; OR, 1.636, p = 0.040; and OR, 2.601, p = 0.012, respectively). Multivariate logistic regression analysis showed that KIR2DL5A–/2DL5B+ associated with HCV clearance (OR, 2.448, p = 0.027), independent of sex, IL28B, and other KIRs. In contrast, KIR2DL3/2DL3 (OR, 0.610, p = 0.034) as well as 2DL3/2DL3+HLA‐C1 or C1C1 (OR, 0.580, p = 0.017; and OR, 0.639, p = 0.025, respectively) was found associated with chronic HCV infection. The presence of the homozygous KIR2DL3 with or without its HLA ligand increased the OR of developing chronic HCV infection in the context of IL28B.CONCLUSIONS: In this study we identified KIR2DL5A–/2DL5B+ associated with HCV spontaneous clearance, while KIR2DL3/2DL3, 2DL3/2DL3+HLA‐C1, or C1C1 associated with chronic infection. Our study highlighted the fact that the roles of KIR and KIR‐HLA contributed to the control of HCV infection by innate immune responses.
- 15 February 2018
- Published by Wiley in Transfusion
- Vol. 58 (4) , 1028-1035
Association of killer cell immunoglobulin‐like receptors with spontaneous clearance of hepatitis C virus in the Chinese population
BACKGROUND: Natural killer (NK) cells are critical components in innate immune response to viral infection. Killer cell immunoglobulin‐like receptors (KIRs) are involved in regulating the balance of activation or inhibitory function of NK cells. However, the association of KIRs with the spontaneous clearance of hepatitis C virus (HCV) remains unclear in the Chinese population.STUDY DESIGN AND METHODS: A total of 407 HCV‐seropositive voluntary blood donors were recruited, including 203 with spontaneous viral clearance and 204 with chronic infection. The presence of KIR genes was detected individually by polymerase chain reaction with sequence‐specific primers. Data of HLA and interleukin‐28B (IL28B) genotypes were extracted from our previous study.RESULTS: Our results showed that KIR2DL2, 2DS2, 2DL2/2DL3, and 2DL5A–/2DL5B+ were more frequent in subjects with HCV clearance than those with chronic infection (odds ratio [OR], 1.640, p = 0.034; OR, 1.664, p = 0.032; OR, 1.636, p = 0.040; and OR, 2.601, p = 0.012, respectively). Multivariate logistic regression analysis showed that KIR2DL5A–/2DL5B+ associated with HCV clearance (OR, 2.448, p = 0.027), independent of sex, IL28B, and other KIRs. In contrast, KIR2DL3/2DL3 (OR, 0.610, p = 0.034) as well as 2DL3/2DL3+HLA‐C1 or C1C1 (OR, 0.580, p = 0.017; and OR, 0.639, p = 0.025, respectively) was found associated with chronic HCV infection. The presence of the homozygous KIR2DL3 with or without its HLA ligand increased the OR of developing chronic HCV infection in the context of IL28B.CONCLUSIONS: In this study we identified KIR2DL5A–/2DL5B+ associated with HCV spontaneous clearance, while KIR2DL3/2DL3, 2DL3/2DL3+HLA‐C1, or C1C1 associated with chronic infection. Our study highlighted the fact that the roles of KIR and KIR‐HLA contributed to the control of HCV infection by innate immune responses.
- 20 July 2017
- Published by Wiley in Journal of Medical Virology
- Vol. 89 (11) , 2037-2040
An evaluation of asymptomatic Dengue infections among blood donors during the 2014 Dengue outbreak in Guangzhou, China
In 2014, an outbreak of dengue virus (DENV) infection led to 45 171 clinical cases diagnosed in Guangdong province, Southern China. However, the potential risk of blood donors asymptomatically infected with DENV has not been evaluated . In the current study we detected anti-DENV IgG antibody and RNA in volunteer Chinese blood donors. We found that anti-DENV IgG antibody was positively detected in 3.4% (51/1500) and two donors were detected as being DENV RNA positive out of 3000 blood samples. We concluded that the presence of potential DENV in blood donors might be potential risk for blood safety. Therefore, screening for DENV infection should be considered in blood donations during a period of dengue outbreak in high epidemic area of China.
- 20 July 2017
- Published by Wiley in Journal of Medical Virology
- Vol. 89 (11) , 2037-2040
An evaluation of asymptomatic Dengue infections among blood donors during the 2014 Dengue outbreak in Guangzhou, China
In 2014, an outbreak of dengue virus (DENV) infection led to 45 171 clinical cases diagnosed in Guangdong province, Southern China. However, the potential risk of blood donors asymptomatically infected with DENV has not been evaluated . In the current study we detected anti-DENV IgG antibody and RNA in volunteer Chinese blood donors. We found that anti-DENV IgG antibody was positively detected in 3.4% (51/1500) and two donors were detected as being DENV RNA positive out of 3000 blood samples. We concluded that the presence of potential DENV in blood donors might be potential risk for blood safety. Therefore, screening for DENV infection should be considered in blood donations during a period of dengue outbreak in high epidemic area of China.